Andrew completed his PhD studying immunity to parasitic worms (helminths) at the Institute of Immunology and Infection Research (IIIR), University of Edinburgh, in 1998. After several years in the U.S., first at Cornell University and then at the University of Pennsylvania, he returned to the UK in 2002 to the University of Edinburgh where he established his lab through successive MRC Career Development and Senior Fellowships at IIIR. In January 2013 he took up the position of Professor of Immunology at the University of Manchester at the Manchester Collaborative Centre for Inflammation Research, which was established in 2012 to address current priorities in inflammatory disease in an innovative collaboration between the University of Manchester, AstraZeneka and GSK. In 2024, he returned to IIIR and the University of Edinburgh to take up the position of Professor of Cellular Immunology. His research addresses some outstanding fundamental questions about activation and modulation of innate and adaptive immunity, with a particular emphasis on Type 2 inflammation, which is a defining feature of infection with helminths, as well as being responsible for widespread suffering in allergies.
Email: andrew.macdonald@ed.ac.uk
Bluesky: profandrewmac.bsky.social
